Payors

• In 2022, the estimated cost for diabetes was $412.9 billion.¹
• People diagnosed with diabetes account for 1 in 4 healthcare dollars in the U.S.¹
• Diabetes patients have medical expenditures 2.6 times higher than patients without diabetes.¹

MiPHR is focused on collaborative efforts to reduce costs while improving care quality. Here is how we support our payor partners.

1. Type 2 Diabetes Prevention Programs: Investing in prevention programs can significantly reduce the incidence of diabetes. Supporting initiatives that promote healthy lifestyles can lead to long-term savings.
2. Patient Education: Empowering patients with knowledge about prediabetes management can reduce the risk of becoming a type 2 diabetic and avoid the associated costs.
3. Value-Based Care Models: Transitioning to value-based care can encourage providers to focus on outcomes rather than volume, ultimately leading to more efficient and effective management of prediabetes.

By working together, we can create a sustainable approach to managing prediabetes care that benefits all stakeholders.

1. Economic Costs of Diabetes in the U.S. in 2022 (https://doi.org/10.2337/dci23-0085)